{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:07:56Z","timestamp":1787166476687,"version":"build-2736575974"},"reference-count":103,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T00:00:00Z","timestamp":1628899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The incidence of neoplastic diseases has increased worldwide, with an estimated global burden of 19.3 million incident cases and 10 million deaths in 2020\u2014a considerable increase compared with 9.6 million deaths in 2018. One of the most prevalent problems faced by patients with cancer and their physicians is malnutrition. It is estimated that patients with cancer have important nutritional alterations in 25% to 70% of cases, which directly affects many spheres of patient care and well-being, including quality of life, treatment toxicity, and survival outcomes. Despite the overwhelming need to address this pressing issue, current evidence in terms of pharmacologic interventions for cancer-related anorexia remains inconclusive, and there is no current standard of care for patients with cancer-related anorexia. Nonetheless, international guidelines recommend promoting anabolism through nutritional, physical, and pharmacologic therapies. In this review, the available information is summarized regarding pharmacologic therapies to treat cancer-related anorexia and findings are highlighted from a clinical stance.<\/jats:p>","DOI":"10.1093\/nutrit\/nuab045","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T07:09:21Z","timestamp":1624345761000},"page":"857-873","source":"Crossref","is-referenced-by-count":13,"title":["<b>Appetite stimulants for<\/b>\n                    \u2002\n                    <b>patients with cancer: current evidence for clinical practice<\/b>"],"prefix":"10.1093","volume":"80","author":[{"given":"Jenny G","family":"Turcott","sequence":"first","affiliation":[{"name":"Thoracic Oncology Unit, Instituto Nacional de Cancerolog\u00eda, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zyanya Lucia","family":"Zatarain-Barr\u00f3n","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Unit, Instituto Nacional de Cancerolog\u00eda, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"C\u00e1rdenas Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Unit, Instituto Nacional de Cancerolog\u00eda, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Tamara","family":"Casta\u00f1ares Bola\u00f1os","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Unit, Instituto Nacional de Cancerolog\u00eda, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1164-3779","authenticated-orcid":false,"given":"Oscar","family":"Arrieta","sequence":"additional","affiliation":[{"name":"Thoracic Oncology Unit, Instituto Nacional de Cancerolog\u00eda, Mexico City, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,8,14]]},"reference":[{"key":"2022031006054636200_nuab045-B1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ijc.31664","article-title":"Global cancer incidence in older adults, 2012 and 2035: a population-based study","volume":"144","author":"Pilleron","year":"2019","journal-title":"Int J Cancer."},{"key":"2022031006054636200_nuab045-B2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics\u201d","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin Nutr."},{"key":"2022031006054636200_nuab045-B3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/01635581.2019.1633362","article-title":"Baseline dysgeusia in chemotherapy-naive non-small cell lung cancer patients: association with nutrition and quality of life","volume":"72","author":"Turcott","year":"2020","journal-title":"Nutr Cancer"},{"key":"2022031006054636200_nuab045-B4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1475-2891-9-15","article-title":"Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy","volume":"9","author":"Sanchez-Lara","year":"2010","journal-title":"Nutr J."},{"key":"2022031006054636200_nuab045-B5","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1634\/theoncologist.2015-0058","article-title":"Nutritional status, body surface, and low lean body mass\/body mass index are related to dose reduction and severe gastrointestinal toxicity induced by afatinib in patients with non-small cell lung cancer","volume":"20","author":"Arrieta","year":"2015","journal-title":"Oncologist."},{"key":"2022031006054636200_nuab045-B6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2407-10-50","article-title":"Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study","volume":"10","author":"Arrieta","year":"2010","journal-title":"BMC Cancer"},{"key":"2022031006054636200_nuab045-B7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2147\/TCRM.S126849","article-title":"Dronabinol oral solution in the management of anorexia and weight loss in AIDS and cancer","volume":"14","author":"Badowski","year":"2018","journal-title":"Ther Clin Risk Manag."},{"key":"2022031006054636200_nuab045-B8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr."},{"key":"2022031006054636200_nuab045-B9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1080\/01635581.2012.668744","article-title":"Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study","volume":"64","author":"Sanchez-Lara","year":"2012","journal-title":"Nutr Cancer."},{"key":"2022031006054636200_nuab045-B10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1200\/JCO.2002.20.2.567","article-title":"Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study","volume":"20","author":"Jatoi","year":"2002","journal-title":"J Clin Oncol."},{"key":"2022031006054636200_nuab045-B11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s005200050281","article-title":"The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients","volume":"8","author":"Walsh","year":"2000","journal-title":"Support Care Cancer."},{"key":"2022031006054636200_nuab045-B12","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"2022031006054636200_nuab045-B13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/082585979401000105","article-title":"A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia","volume":"10","author":"Nelson","year":"1994","journal-title":"J Palliat Care."},{"key":"2022031006054636200_nuab045-B14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jpainsymman.2005.11.007","article-title":"The efficacy and tolerability of long-term use of dronabinol in cancer-related anorexia: a case series","volume":"30","author":"Walsh","year":"2005","journal-title":"J Pain Symptom Manage."},{"key":"2022031006054636200_nuab045-B15","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.2005.05.1847","article-title":"Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group","volume":"24","author":"Strasser","year":"2006","journal-title":"J Clin Oncol."},{"key":"2022031006054636200_nuab045-B16","first-page":"119","article-title":"Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring","volume":"6","author":"Maida","year":"2008","journal-title":"J Support Oncol"},{"key":"2022031006054636200_nuab045-B17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","article-title":"Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain","volume":"39","author":"Johnson","year":"2010","journal-title":"J Pain Symptom Manage."},{"key":"2022031006054636200_nuab045-B18","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/annonc\/mdq727","article-title":"Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial","volume":"22","author":"Brisbois","year":"2011","journal-title":"Ann Oncol"},{"key":"2022031006054636200_nuab045-B19","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/0003489415612801","article-title":"Improving quality of life with nabilone during radiotherapy treatments for head and neck cancers: a randomized double-blind placebo-controlled trial","volume":"125","author":"C\u00f4t\u00e9","year":"2016","journal-title":"Ann Otol Rhinol Laryngol."},{"key":"2022031006054636200_nuab045-B20","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1007\/s00520-018-4154-9","article-title":"The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial","volume":"26","author":"Turcott","year":"2018","journal-title":"Support Care Cancer."},{"key":"2022031006054636200_nuab045-B21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21037\/apm.2018.08.04","article-title":"Health-related quality of life across cancer cachexia stages","volume":"8","author":"Kasvis","year":"2019","journal-title":"Ann Palliat Med."},{"key":"2022031006054636200_nuab045-B22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S0885-3924(02)00381-0","article-title":"An open-label, crossover trial of mirtazapine (15 and 30 mg) in cancer patients with pain and other distressing symptoms","volume":"23","author":"Theobald","year":"2002","journal-title":"J Pain Symptom Manag"},{"key":"2022031006054636200_nuab045-B23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/1049909109345685","article-title":"Phase II trial of mirtazapine for cancer-related cachexia and anorexia","volume":"27","author":"Riechelmann","year":"2010","journal-title":"Am J Hosp Palliat Care."},{"key":"2022031006054636200_nuab045-B24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/1060028018802816","article-title":"Efficacy and safety of appetite-stimulating medications in the inpatient setting","volume":"53","author":"Howard","year":"2019","journal-title":"Ann Pharmacother."},{"key":"2022031006054636200_nuab045-B25","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.2147\/CMAR.S191330","article-title":"Low-dose of olanzapine has ameliorating effects on cancer-related anorexia","volume":"11","author":"Okamoto","year":"2019","journal-title":"Cancer Manag Res."},{"key":"2022031006054636200_nuab045-B26","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/sj.bjc.6604148","article-title":"Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia\/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study","volume":"98","author":"Strasser","year":"2008","journal-title":"Br J Cancer."},{"key":"2022031006054636200_nuab045-B27","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/cncr.24917","article-title":"Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients: a randomized double-blind study","volume":"116","author":"Lundholm","year":"2010","journal-title":"Cancer"},{"key":"2022031006054636200_nuab045-B28","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1007\/s00520-016-3144-z","article-title":"Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial","volume":"24","author":"Takayama","year":"2016","journal-title":"Support Care Cancer."},{"key":"2022031006054636200_nuab045-B29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S1470-2045(15)00558-6","article-title":"Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials","volume":"17","author":"Temel","year":"2016","journal-title":"Lancet Oncol"},{"key":"2022031006054636200_nuab045-B30","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/annonc\/mdx192","article-title":"ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia","volume":"28","author":"Currow","year":"2017","journal-title":"Ann Oncol"},{"key":"2022031006054636200_nuab045-B31","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/cncr.31128","article-title":"Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04)","volume":"124","author":"Katakami","year":"2018","journal-title":"Cancer"},{"key":"2022031006054636200_nuab045-B32","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1002\/cncr.32406","article-title":"A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in advanced gastrointestinal cancer patients with cancer cachexia","volume":"125","author":"Hamauchi","year":"2019","journal-title":"Cancer"},{"key":"2022031006054636200_nuab045-B33","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/0899-9007(95)00078-X","article-title":"The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer","volume":"12","author":"Wigmore","year":"1996","journal-title":"Nutrition"},{"key":"2022031006054636200_nuab045-B34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.bjc.6690654","article-title":"The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer","volume":"81","author":"Barber","year":"1999","journal-title":"Br J Cancer."},{"key":"2022031006054636200_nuab045-B35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1207\/S15327914NC3602_6","article-title":"Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer","volume":"36","author":"Wigmore","year":"2000","journal-title":"Nutr Cancer."},{"key":"2022031006054636200_nuab045-B36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1207\/S15327914NC402_7","article-title":"Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia","volume":"40","author":"Barber","year":"2001","journal-title":"Nutr Cancer."},{"key":"2022031006054636200_nuab045-B37","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/gut.52.10.1479","article-title":"Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial","volume":"52","author":"Fearon","year":"2003","journal-title":"Gut"},{"key":"2022031006054636200_nuab045-B38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1200\/JCO.2003.01.101","article-title":"Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia\/cachexia: a double-blind, placebo-controlled study","volume":"21","author":"Bruera","year":"2003","journal-title":"J Clin Oncol."},{"key":"2022031006054636200_nuab045-B39","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.bjc.6601620","article-title":"Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids","volume":"90","author":"Moses","year":"2004","journal-title":"Br J Cancer."},{"key":"2022031006054636200_nuab045-B40","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1200\/JCO.2004.06.024","article-title":"An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort","volume":"22","author":"Jatoi","year":"2004","journal-title":"J Clin Oncol."},{"key":"2022031006054636200_nuab045-B41","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1200\/JCO.2005.04.5724","article-title":"Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia","volume":"24","author":"Fearon","year":"2006","journal-title":"J Clin Oncol."},{"key":"2022031006054636200_nuab045-B42","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3945\/jn.110.121202","article-title":"Oral nutritional supplements containing (n-3) polyunsaturated fatty acids affect the nutritional status of patients with stage III non-small cell lung cancer during multimodality treatment","volume":"140","author":"van der Meij","year":"2010","journal-title":"J Nutr"},{"key":"2022031006054636200_nuab045-B43","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1002\/cncr.25933","article-title":"Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer","volume":"117","author":"Murphy","year":"2011","journal-title":"Cancer"},{"key":"2022031006054636200_nuab045-B44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/01635581.2012.643133","article-title":"Fish oil supplement alters markers of inflammatory and nutritional status in colorectal cancer patients","volume":"64","author":"Silva","year":"2012","journal-title":"Nutr Cancer."},{"key":"2022031006054636200_nuab045-B45","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1017\/S0007114511005551","article-title":"Effect of n-3 fatty acids on patients with advanced lung cancer: a double-blind, placebo-controlled study","volume":"108","author":"Finocchiaro","year":"2012","journal-title":"Br J Nutr."},{"key":"2022031006054636200_nuab045-B46","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.clnu.2014.03.006","article-title":"Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: randomised trial","volume":"33","author":"S\u00e1nchez-Lara","year":"2014","journal-title":"Clin Nutr"},{"key":"2022031006054636200_nuab045-B47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12944-017-0495-5","article-title":"Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial","volume":"16","author":"Werner","year":"2017","journal-title":"Lipids Health Dis."},{"key":"2022031006054636200_nuab045-B48","first-page":"2369","article-title":"Effects of omega-3 fatty acid supplementation in patients with bile duct or pancreatic cancer undergoing chemotherapy","volume":"38","author":"Abe","year":"2018","journal-title":"Anticancer Res."},{"key":"2022031006054636200_nuab045-B49","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol."},{"key":"2022031006054636200_nuab045-B50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1517\/13543784.17.1.85","article-title":"Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain","volume":"17","author":"Davis","year":"2008","journal-title":"Expert Opin Investig Drugs."},{"key":"2022031006054636200_nuab045-B51","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/MCO.0b013e3281900ecc","article-title":"Endocannabinoid system in cancer cachexia","volume":"10","author":"Osei-Hyiaman","year":"2007","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"2022031006054636200_nuab045-B52","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.beem.2009.02.001","article-title":"Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents","volume":"23","author":"Pisanti","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"2022031006054636200_nuab045-B53","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","article-title":"Leptin-regulated endocannabinoids are involved in maintaining food intake","volume":"410","author":"Di Marzo","year":"2001","journal-title":"Nature"},{"key":"2022031006054636200_nuab045-B54","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/09540260902782810","article-title":"Cannabinoids and appetite: food craving and food pleasure","volume":"21","author":"Kirkham","year":"2009","journal-title":"Int Rev Psychiatry."},{"key":"2022031006054636200_nuab045-B55","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1136\/bmj.314.7098.1845","article-title":"Vitamin E and cardiovascular protection in diabetes","volume":"314","author":"Gazis","year":"1997","journal-title":"BMJ."},{"key":"2022031006054636200_nuab045-B56","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"Br J Pharmacol."},{"key":"2022031006054636200_nuab045-B57","first-page":"518909","article-title":"Structure and physiological actions of ghrelin","volume":"2013","author":"Delporte","year":"2013","journal-title":"Scientifica (Cairo)."},{"key":"2022031006054636200_nuab045-B58","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000057464","article-title":"Effects of neuropeptide Y on appetite","volume":"25","author":"Kokot","year":"1999","journal-title":"Miner Electrolyte Metab."},{"key":"2022031006054636200_nuab045-B59","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.nut.2014.12.002","article-title":"Eicosapentaenoic acid in cancer improves body composition and modulates metabolism","volume":"31","author":"Pappalardo","year":"2015","journal-title":"Nutrition."},{"key":"2022031006054636200_nuab045-B60","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00520-002-0387-7","article-title":"Established and potential therapeutic applications of cannabinoids in oncology","volume":"11","author":"Walsh","year":"2003","journal-title":"Support Care Cancer."},{"key":"2022031006054636200_nuab045-B61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0885-3924(94)00117-4","article-title":"Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS","volume":"10","author":"Beal","year":"1995","journal-title":"J Pain Symptom Manage."},{"key":"2022031006054636200_nuab045-B62","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1527-3458.2001.tb00198.x","article-title":"A review of the pharmacological and clinical profile of mirtazapine","volume":"7","author":"Anttila","year":"2001","journal-title":"CNS Drug Rev."},{"key":"2022031006054636200_nuab045-B63","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4103\/IJPC.IJPC_17_17","article-title":"Effect of mirtazapine on gastric emptying in patients with cancer-associated anorexia","volume":"23","author":"Kumar","year":"2017","journal-title":"Indian J Palliat Care."},{"key":"2022031006054636200_nuab045-B64","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4140\/TCP.n.2014.124","article-title":"Potential role of mirtazapine in underweight older adults","volume":"29","author":"Hilas","year":"2014","journal-title":"Consult Pharm."},{"key":"2022031006054636200_nuab045-B65","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.gerinurse.2019.08.012","article-title":"Should mirtazapine be used to improve appetite and reverse weight loss?","volume":"40","author":"Simonson","year":"2019","journal-title":"Geriatr Nurs."},{"key":"2022031006054636200_nuab045-B66","year":"2018"},{"key":"2022031006054636200_nuab045-B67","first-page":"CD006528","article-title":"Mirtazapine versus other antidepressive agents for depression","author":"Watanabe","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2022031006054636200_nuab045-B68","doi-asserted-by":"crossref","first-page":"421","DOI":"10.4088\/JCP.v67n0313","article-title":"Effect of mirtazapine treatment on body composition and metabolism","volume":"67","author":"Laimer","year":"2006","journal-title":"J Clin Psychiatry."},{"key":"2022031006054636200_nuab045-B69","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/CCO.0b013e3283479c66","article-title":"Nutritional intervention for improving treatment tolerance in cancer patients","volume":"23","author":"Paccagnella","year":"2011","journal-title":"Curr Opin Oncol."},{"key":"2022031006054636200_nuab045-B70","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1017\/S000711450765795X","article-title":"N-3 fatty acids, cancer and cachexia: a systematic review of the literature","volume":"97","author":"Colomer","year":"2007","journal-title":"Br J Nutr."},{"key":"2022031006054636200_nuab045-B71","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.appet.2019.02.012","article-title":"Use of cyproheptadine to stimulate appetite and body weight gain: a systematic review","volume":"137","author":"Harrison","year":"2019","journal-title":"Appetite"},{"key":"2022031006054636200_nuab045-B72","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0899-9007(01)00506-8","article-title":"Cancer anorexia and cachexia","volume":"17","author":"Tisdale","year":"2001","journal-title":"Nutrition."},{"key":"2022031006054636200_nuab045-B73","doi-asserted-by":"crossref","first-page":"8500","DOI":"10.1200\/JCO.2005.01.8010","article-title":"Systematic review of the treatment of cancer-associated anorexia and weight loss","volume":"23","author":"Yavuzsen","year":"2005","journal-title":"J Clin Oncol."},{"key":"2022031006054636200_nuab045-B74","doi-asserted-by":"crossref","first-page":"636","DOI":"10.20452\/pamw.510","article-title":"Effects of megestrol acetate in patients with cancer anorexia-cachexia syndrome\u2013a systematic review and meta-analysis","volume":"118","author":"Le\u015bniak","year":"2008","journal-title":"Pol Arch Med Wewn."},{"key":"2022031006054636200_nuab045-B75","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2298\/MPNS0812571S","article-title":"[Influence of dexamethasone on appetite and body weight in lung cancer patients]","volume":"61","author":"Sarcev","year":"2008","journal-title":"Med Pregl."},{"key":"2022031006054636200_nuab045-B76","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1089\/jpm.2013.0324","article-title":"Use of corticosteroids for anorexia in palliative medicine: a systematic review","volume":"17","author":"Miller","year":"2014","journal-title":"J Palliat Med."},{"key":"2022031006054636200_nuab045-B77","doi-asserted-by":"crossref","first-page":"86","DOI":"10.21037\/apm.2018.08.02","article-title":"Sarcopenia associated with chemotherapy and targeted agents for cancer therapy","volume":"8","author":"Davis","year":"2019","journal-title":"Ann Palliat Med."},{"key":"2022031006054636200_nuab045-B78","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1016\/j.bmc.2017.04.018","article-title":"Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidate","volume":"25","author":"Aikawa","year":"2017","journal-title":"Bioorg Med Chem."},{"key":"2022031006054636200_nuab045-B79","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.bmcl.2017.03.038","article-title":"Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part II: optimization of 4-(pyrrolidin-1-yl)benzonitrile derivatives","volume":"27","author":"Asano","year":"2017","journal-title":"Bioorg Med Chem Lett."},{"key":"2022031006054636200_nuab045-B80","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1200\/JCO.2012.43.6766","article-title":"Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial","volume":"31","author":"Del Fabbro","year":"2013","journal-title":"J Clin Oncol."},{"key":"2022031006054636200_nuab045-B81","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1200\/JCO.1995.13.11.2856","article-title":"Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial","volume":"13","author":"Goldberg","year":"1995","journal-title":"J Clin Oncol."},{"key":"2022031006054636200_nuab045-B82","first-page":"CD008664","article-title":"Thalidomide for managing cancer cachexia","author":"Reid","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2022031006054636200_nuab045-B83","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/1097-0142(19870201)59:3<406::AID-CNCR2820590309>3.0.CO;2-W","article-title":"Hydrazine sulfate in cancer patients with weight loss. A placebo-controlled clinical experience","volume":"59","author":"Chlebowski","year":"1987","journal-title":"Cancer"},{"key":"2022031006054636200_nuab045-B84","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2165\/00003495-199855050-00005","article-title":"A review of the drug treatment of cachexia associated with cancer","volume":"55","author":"Gagnon","year":"1998","journal-title":"Drugs"},{"key":"2022031006054636200_nuab045-B85","first-page":"17","article-title":"Pharmacological therapy of cancer anorexia-cachexia","volume":"21(suppl 3","author":"Cardona","year":"2006","journal-title":"Nutr Hosp."},{"key":"2022031006054636200_nuab045-B86","first-page":"345","article-title":"l-Carnitine: therapeutic applications of a conditionally-essential amino acid","volume":"3","year":"1998","journal-title":"Altern Med Rev"},{"key":"2022031006054636200_nuab045-B87","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jpainsymman.2006.09.001","article-title":"Safety, tolerability and symptom outcomes associated with l-carnitine supplementation in patients with cancer, fatigue, and carnitine deficiency: a phase I\/II study","volume":"32","author":"Cruciani","year":"2006","journal-title":"J Pain Symptom Manag"},{"key":"2022031006054636200_nuab045-B88","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.nut.2005.06.003","article-title":"Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy","volume":"22","author":"Gramignano","year":"2006","journal-title":"Nutrition."},{"key":"2022031006054636200_nuab045-B89","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1634\/theoncologist.2009-0153","article-title":"Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia","volume":"15","author":"Mantovani","year":"2010","journal-title":"Oncologist."},{"key":"2022031006054636200_nuab045-B90","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.clnu.2011.10.005","article-title":"Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib \u00b1 megestrol acetate for patients with cancer-related anorexia\/cachexia syndrome","volume":"31","author":"Madeddu","year":"2012","journal-title":"Clin Nutr."},{"key":"2022031006054636200_nuab045-B91","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-2891-11-52","article-title":"l-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)\u2013a randomized multicentre trial","volume":"11","author":"Kraft","year":"2012","journal-title":"Nutr J."},{"key":"2022031006054636200_nuab045-B92","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1158\/1078-0432.CCR-06-2720","article-title":"Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning","volume":"13","author":"Lundholm","year":"2007","journal-title":"Clin Cancer Res."},{"key":"2022031006054636200_nuab045-B93","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1634\/theoncologist.2011-0151","article-title":"Preliminary report: vitamin D deficiency in advanced cancer patients with symptoms of fatigue or anorexia","volume":"16","author":"Dev","year":"2011","journal-title":"Oncologist"},{"key":"2022031006054636200_nuab045-B94","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.15252\/embj.201696151","article-title":"Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine","volume":"36","author":"Zhang","year":"2017","journal-title":"Embo J."},{"key":"2022031006054636200_nuab045-B95","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.clnu.2014.03.007","article-title":"Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia","volume":"33","author":"Biolo","year":"2014","journal-title":"Clin Nutr."},{"key":"2022031006054636200_nuab045-B96","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.clnesp.2016.08.003","article-title":"The effect of glutamine and arginine-enriched nutritional support on quality of life in head and neck cancer patients treated with IMRT","volume":"16","author":"Yuce Sari","year":"2016","journal-title":"Clin Nutr Espen."},{"key":"2022031006054636200_nuab045-B97","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1007\/s00520-019-04892-0","article-title":"Systematic review of agents for the management of cancer treatment-related gastrointestinal mucositis and clinical practice guidelines","volume":"27","author":"Bowen","year":"2019","journal-title":"Support Care Cancer."},{"key":"2022031006054636200_nuab045-B98","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00520-012-1644-z","article-title":"Systematic review of agents for the management of gastrointestinal mucositis in cancer patients","volume":"21","author":"Gibson","year":"2013","journal-title":"Support Care Cancer."},{"key":"2022031006054636200_nuab045-B99","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/MCO.0000000000000339","article-title":"Glutamine and the regulation of intestinal permeability: from bench to bedside","volume":"20","author":"Achamrah","year":"2017","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"2022031006054636200_nuab045-B100","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/2212798411103030226","article-title":"Zinc as an appetite stimulator - the possible role of zinc in the progression of diseases such as cachexia and sarcopenia","volume":"3","author":"Suzuki","year":"2011","journal-title":"Recent Pat Food Nutr Agric."},{"key":"2022031006054636200_nuab045-B101","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3945\/jn.108.096370","article-title":"Orally administered zinc increases food intake via vagal stimulation in rats","volume":"139","author":"Ohinata","year":"2009","journal-title":"J Nutr."},{"key":"2022031006054636200_nuab045-B102","doi-asserted-by":"crossref","first-page":"624","DOI":"10.12669\/pjms.35.3.503","article-title":"Efficacy of zinc sulfate on concurrent chemoradiotherapy induced taste alterations in oral cancer patients: a double blind randomized controlled trial","volume":"35","author":"Khan","year":"2019","journal-title":"Pak J Med Sci."},{"key":"2022031006054636200_nuab045-B103","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/15360288.2012.676618","article-title":"A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders","volume":"26","author":"Lyckholm","year":"2012","journal-title":"J Pain Palliat Care Pharmacother."}],"container-title":["Nutrition Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/80\/4\/857\/42785363\/nuab045.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/80\/4\/857\/42785363\/nuab045.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T06:19:46Z","timestamp":1725257986000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article\/80\/4\/857\/6352185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,14]]},"references-count":103,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,8,14]]},"published-print":{"date-parts":[[2022,3,10]]}},"URL":"https:\/\/doi.org\/10.1093\/nutrit\/nuab045","relation":{},"ISSN":["0029-6643","1753-4887"],"issn-type":[{"value":"0029-6643","type":"print"},{"value":"1753-4887","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,1]]},"published":{"date-parts":[[2021,8,14]]}}}